193 related articles for article (PubMed ID: 24495796)
1. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
[TBL] [Abstract][Full Text] [Related]
2. HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis.
Sun M; Song CX; Huang H; Frankenberger CA; Sankarasharma D; Gomes S; Chen P; Chen J; Chada KK; He C; Rosner MR
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9920-5. PubMed ID: 23716660
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment.
Wawrzyniak D; Grabowska M; Głodowicz P; Kuczyński K; Kuczyńska B; Fedoruk-Wyszomirska A; Rolle K
PLoS One; 2020; 15(8):e0237889. PubMed ID: 32817625
[TBL] [Abstract][Full Text] [Related]
4. Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer.
Xie W; Xu H; Cheng Y; Lin X; Zeng J; Sun Y
Technol Cancer Res Treat; 2024; 23():15330338241254219. PubMed ID: 38780484
[TBL] [Abstract][Full Text] [Related]
5. NKAIN1, as an oncogene, promotes the proliferation and metastasis of breast cancer, affecting its prognosis.
Wang X; Yang F; Sun Z; Zhao G; Pu Q; Geng C; Dong K; Zhang X; Liu Z; Song H
Mol Carcinog; 2024 Jul; 63(7):1392-1405. PubMed ID: 38651944
[TBL] [Abstract][Full Text] [Related]
6. A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker.
Bii VM; Rae DT; Trobridge GD
Oncotarget; 2015 Nov; 6(37):39507-20. PubMed ID: 26506596
[TBL] [Abstract][Full Text] [Related]
7. Antioxydation And Cell Migration Genes Are Identified as Potential Therapeutic Targets in Basal-Like and BRCA1 Mutated Breast Cancer Cell Lines.
Privat M; Rudewicz J; Sonnier N; Tamisier C; Ponelle-Chachuat F; Bignon YJ
Int J Med Sci; 2018; 15(1):46-58. PubMed ID: 29333087
[TBL] [Abstract][Full Text] [Related]
8. Involvement of large tenascin-C splice variants in breast cancer progression.
Tsunoda T; Inada H; Kalembeyi I; Imanaka-Yoshida K; Sakakibara M; Okada R; Katsuta K; Sakakura T; Majima Y; Yoshida T
Am J Pathol; 2003 Jun; 162(6):1857-67. PubMed ID: 12759243
[TBL] [Abstract][Full Text] [Related]
9. ZC3H12A inhibits tumor growth and metastasis of breast cancer under hypoxic condition via the inactivation of IL-17 signaling pathway.
Luo Z; Yang F; Liu K; Ding Z
Cell Cycle; 2024 Jan; 23(2):188-204. PubMed ID: 38357935
[TBL] [Abstract][Full Text] [Related]
10. Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
Mbugua RW; Takano A; Tsevegjav B; Yokose T; Yamashita T; Miyagi Y; Daigo Y
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426627
[TBL] [Abstract][Full Text] [Related]
11. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Grigoriadis A; Mackay A; Reis-Filho JS; Steele D; Iseli C; Stevenson BJ; Jongeneel CV; Valgeirsson H; Fenwick K; Iravani M; Leao M; Simpson AJ; Strausberg RL; Jat PS; Ashworth A; Neville AM; O'Hare MJ
Breast Cancer Res; 2006; 8(5):R56. PubMed ID: 17014703
[TBL] [Abstract][Full Text] [Related]
12. Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.
Yu H; Jiang Y; Liu L; Shan W; Chu X; Yang Z; Yang ZQ
Oncotarget; 2017 Feb; 8(8):13099-13115. PubMed ID: 28055972
[TBL] [Abstract][Full Text] [Related]
13. Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer.
Athreya AP; Kalari KR; Cairns J; Gaglio AJ; Wills QF; Niu N; Weinshilboum R; Iyer RK; Wang L
Oncotarget; 2017 Apr; 8(16):27199-27215. PubMed ID: 28423712
[TBL] [Abstract][Full Text] [Related]
14. SUN-MKL1 Crosstalk Regulates Nuclear Deformation and Fast Motility of Breast Carcinoma Cells in Fibrillar ECM Microenvironment.
Sharma VP; Williams J; Leung E; Sanders J; Eddy R; Castracane J; Oktay MH; Entenberg D; Condeelis JS
Cells; 2021 Jun; 10(6):. PubMed ID: 34205257
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer.
Xie W; Sun Y; Zeng Y; Hu L; Zhi J; Ling H; Zheng X; Ruan X; Gao M
Bioengineered; 2022 Jan; 13(1):190-205. PubMed ID: 34964699
[TBL] [Abstract][Full Text] [Related]
16. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
[TBL] [Abstract][Full Text] [Related]
17. Significant random signatures reveals new biomarker for breast cancer.
Saberi Ansar E; Eslahchii C; Rahimi M; Geranpayeh L; Ebrahimi M; Aghdam R; Kerdivel G
BMC Med Genomics; 2019 Nov; 12(1):160. PubMed ID: 31703592
[TBL] [Abstract][Full Text] [Related]
18. Uncovering temperature-dependent extracellular vesicle secretion in breast cancer.
Otsuka K; Yamamoto Y; Ochiya T
J Extracell Vesicles; 2020 Dec; 10(2):e12049. PubMed ID: 33408817
[TBL] [Abstract][Full Text] [Related]
19. Prognostic gene expression signatures of breast cancer are lacking a sensible biological meaning.
Manjang K; Tripathi S; Yli-Harja O; Dehmer M; Glazko G; Emmert-Streib F
Sci Rep; 2021 Jan; 11(1):156. PubMed ID: 33420139
[TBL] [Abstract][Full Text] [Related]
20. Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival.
Nair NU; Das A; Rogkoti VM; Fokkelman M; Marcotte R; de Jong CG; Koedoot E; Lee JS; Meilijson I; Hannenhalli S; Neel BG; de Water BV; Le Dévédec SE; Ruppin E
Sci Rep; 2019 Jul; 9(1):10989. PubMed ID: 31358840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
